Kezar Life Sciences, Inc.

KZR

Held by 1 specialist biotech fund

1 fund opened new positions. Short interest: 2.1% of float.

Share

Signal Score

1.5/10

1 fund opened new positions

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Tang Capital ManagementNew

Short Interest

Shorts covering

Short Shares

152K

Change

-21.2%

Days to Cover

1.3

% of Float

2.1%

Settlement

Apr 15, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Position Details

Tang Capital ManagementNEWFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

ENTA1 fund RCKT1 fund ATXS1 fund ATRA1 fund BEAM1 fund BEIGF1 fund BCRX1 fund BIIB1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer